journal article

Journal Article

Text

Development Growth and Differentiation. 2021, 63(1), p. 72-81

Recent progress of animal transplantation studies for treating articular cartilage damage using pluripotent stem cells

Blackwell Publishing

English

Text

2021-01-07

https://doi.org/10.1111/dgd.12706

This is the peer reviewed version of the following article: Yamashita A., Tsumaki N.. Recent progress of animal transplantation studies for treating articular cartilage damage using pluripotent stem cells. Development Growth and Differentiation 63, 72 (2021), which has been published in final form at https://doi.org/10.1111/dgd.12706. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked to Wiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages thereof by third parties from platforms, services and websites other than Wiley Online Library must be prohibited.

Focal articular cartilage damage can eventually lead to the onset of osteoarthritis with degradation around healthy articular cartilage. Currently, there are no drugs available that effectively repair articular cartilage damage. Several surgical techniques exist and are expected to prevent progression to osteoarthritis, but they do not offer a long-term clinical solution. Recently, regenerative medicine approaches using human pluripotent stem cells (PSCs) have gained attention as new cell sources for therapeutic products. To translate PSCs to clinical application, appropriate cultures that produce large amounts of chondrocytes and hyaline cartilage are needed. So too are assays for the safety and efficacy of the cellular materials in preclinical studies including animal transplantation models. To confirm safety and efficacy, transplantation into the subcutaneous space and articular cartilage defects have been performed in animal models. All but one study we reviewed that transplanted PSC-derived cellular products into articular cartilage defects found safe and effective recovery. However, for most of those studies, the quality of the PSCs was not verified, and the evaluations were done with small animals over short observation periods. Large animals and longer observation times are preferred. We will discuss the recent progress and future direction of the animal transplantation studies for the treatment of focal articular cartilage damages using PSCs.

© 2021 Japanese Society of Developmental Biologists

93301

Recent progress of animal transplantation studies for treating articular cartilage damage using pluripotent stem cells

Blackwell Publishing

English

2021-01-07

Development Growth and Differentiation

63

1

72

81

https://doi.org/10.1111/dgd.12706

https://hdl.handle.net/11094/93301